Paul M. Clément
Rega Institute for Medical Research(BE)Universitair Ziekenhuis Leuven(BE)VIB-KU Leuven Center for Cancer Biology(BE)Groupe Hospitalier de la Région de Mulhouse et Sud Alsace(FR)Catholic University of America(US)KU Leuven(BE)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → Lomustine and Bevacizumab in Progressive Glioblastoma(2017)960 cited
- → Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034(2009)563 cited
- → Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study(2016)492 cited
- → Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma(2010)443 cited
- → Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study(2017)395 cited
- → Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial